CY1120728T1 - Παραγωγα διαζεπινονης χρησιμα για τη θεραπεια του συνδρομου ευθραυστου χ, της νοσου toy parkinson ή της γαστρο-οισοφαγικης παλινδρομησης - Google Patents
Παραγωγα διαζεπινονης χρησιμα για τη θεραπεια του συνδρομου ευθραυστου χ, της νοσου toy parkinson ή της γαστρο-οισοφαγικης παλινδρομησηςInfo
- Publication number
- CY1120728T1 CY1120728T1 CY181100599T CY181100599T CY1120728T1 CY 1120728 T1 CY1120728 T1 CY 1120728T1 CY 181100599 T CY181100599 T CY 181100599T CY 181100599 T CY181100599 T CY 181100599T CY 1120728 T1 CY1120728 T1 CY 1120728T1
- Authority
- CY
- Cyprus
- Prior art keywords
- gastro
- esophageal
- parkinson
- fragile
- syndrome
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Η εφεύρεση αναφέρεται στην ένωση του χημικού τύπου (I) ή σε ένα άλας αυτής, όπου οι υποκατάστατες είναι όπως ορίστηκαν στη περιγραφή, στην παρασκευή της, στη χρήση της ως φαρμακευτικό σκεύασμα και σε φαρμακευτικά σκευάσματα που την περιέχουν.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1215033.0A GB201215033D0 (en) | 2012-08-23 | 2012-08-23 | Diazepinone derivatives |
| PCT/IB2013/056782 WO2014030128A1 (en) | 2012-08-23 | 2013-08-21 | Diazepinone derivatives useful for the treatment of fragile x syndrome, parkinsons or reflux disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1120728T1 true CY1120728T1 (el) | 2019-12-11 |
Family
ID=47045285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY181100599T CY1120728T1 (el) | 2012-08-23 | 2018-06-07 | Παραγωγα διαζεπινονης χρησιμα για τη θεραπεια του συνδρομου ευθραυστου χ, της νοσου toy parkinson ή της γαστρο-οισοφαγικης παλινδρομησης |
Country Status (44)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201215033D0 (en) | 2012-08-23 | 2012-10-10 | Novartis Ag | Diazepinone derivatives |
| KR20200035035A (ko) | 2017-07-31 | 2020-04-01 | 노파르티스 아게 | 코카인 사용 감소 또는 코카인 사용 재발 예방에 있어서 마보글루란트의 용도 |
| CN113301894A (zh) * | 2019-01-29 | 2021-08-24 | 诺华股份有限公司 | mGluR5拮抗剂用于治疗阿片类物质镇痛耐受性的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3853851A (en) * | 1972-01-26 | 1974-12-10 | Ciba Geigy Corp | Diazepinoisoquinolines |
| GB0128996D0 (en) | 2001-12-04 | 2002-01-23 | Novartis Ag | Organic compounds |
| US7507836B2 (en) * | 2003-03-26 | 2009-03-24 | Merck & Co. Inc. | Benzamide modulators of metabotropic glutamate receptors |
| GB0413605D0 (en) * | 2004-06-17 | 2004-07-21 | Addex Pharmaceuticals Sa | Novel compounds |
| TW200811157A (en) * | 2006-05-05 | 2008-03-01 | Astrazeneca Ab | mGluR5 modulators I |
| CU20090172A6 (es) | 2009-10-09 | 2011-10-05 | Facultad De Quimica Universidad De La Habana | Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular |
| WO2011075699A2 (en) * | 2009-12-18 | 2011-06-23 | Sunovion Pharmaceuticals Inc. | Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| ES2693152T3 (es) | 2011-05-10 | 2018-12-07 | Kyowa Hakko Kirin Co., Ltd. | Compuesto de pirimido-diazepinona |
| GB201215033D0 (en) | 2012-08-23 | 2012-10-10 | Novartis Ag | Diazepinone derivatives |
-
2012
- 2012-08-23 GB GBGB1215033.0A patent/GB201215033D0/en not_active Ceased
-
2013
- 2013-08-21 PL PL13783671T patent/PL2888259T3/pl unknown
- 2013-08-21 MX MX2015002367A patent/MX365253B/es active IP Right Grant
- 2013-08-21 RS RS20180581A patent/RS57231B1/sr unknown
- 2013-08-21 SI SI201331027T patent/SI2888259T1/en unknown
- 2013-08-21 MA MA37849A patent/MA37849A1/fr unknown
- 2013-08-21 AU AU2013307239A patent/AU2013307239B2/en not_active Ceased
- 2013-08-21 SG SG11201500068QA patent/SG11201500068QA/en unknown
- 2013-08-21 EP EP13783671.4A patent/EP2888259B1/en active Active
- 2013-08-21 JP JP2015527996A patent/JP6169699B2/ja not_active Expired - Fee Related
- 2013-08-21 CN CN201380042195.XA patent/CN104520298B/zh not_active Expired - Fee Related
- 2013-08-21 AP AP2014008140A patent/AP2014008140A0/xx unknown
- 2013-08-21 MY MYPI2014003502A patent/MY170103A/en unknown
- 2013-08-21 NZ NZ703628A patent/NZ703628A/en not_active IP Right Cessation
- 2013-08-21 WO PCT/IB2013/056782 patent/WO2014030128A1/en active Application Filing
- 2013-08-21 PT PT137836714T patent/PT2888259T/pt unknown
- 2013-08-21 NO NO13783671A patent/NO2888259T3/no unknown
- 2013-08-21 BR BR112015003281A patent/BR112015003281A8/pt active Search and Examination
- 2013-08-21 DK DK13783671.4T patent/DK2888259T3/en active
- 2013-08-21 ES ES13783671.4T patent/ES2672737T3/es active Active
- 2013-08-21 LT LTEP13783671.4T patent/LT2888259T/lt unknown
- 2013-08-21 EA EA201590415A patent/EA029493B1/ru not_active IP Right Cessation
- 2013-08-21 CA CA2878564A patent/CA2878564C/en active Active
- 2013-08-21 TR TR2018/07174T patent/TR201807174T4/tr unknown
- 2013-08-21 HU HUE13783671A patent/HUE037971T2/hu unknown
- 2013-08-21 PE PE2015000245A patent/PE20150401A1/es active IP Right Grant
- 2013-08-21 KR KR1020157003903A patent/KR102104149B1/ko active IP Right Grant
- 2013-08-21 UA UAA201413654A patent/UA114326C2/uk unknown
- 2013-08-21 SG SG10201701333WA patent/SG10201701333WA/en unknown
- 2013-08-22 US US13/973,454 patent/US8853203B2/en active Active
- 2013-08-22 UY UY0001034986A patent/UY34986A/es unknown
- 2013-08-22 JO JOP/2013/0250A patent/JOP20130250B1/ar active
- 2013-08-22 TW TW102130096A patent/TWI616444B/zh not_active IP Right Cessation
- 2013-08-23 AR ARP130102989A patent/AR092212A1/es not_active Application Discontinuation
-
2014
- 2014-08-19 US US14/462,813 patent/US9284331B2/en active Active
- 2014-12-18 ZA ZA2014/09345A patent/ZA201409345B/en unknown
- 2014-12-19 TN TN2014000528A patent/TN2014000528A1/fr unknown
-
2015
- 2015-02-02 IL IL237062A patent/IL237062A/en active IP Right Grant
- 2015-02-20 PH PH12015500373A patent/PH12015500373A1/en unknown
- 2015-02-20 CL CL2015000416A patent/CL2015000416A1/es unknown
- 2015-02-23 GT GT201500039A patent/GT201500039A/es unknown
- 2015-02-23 CU CUP2015000016A patent/CU20150016A7/es unknown
- 2015-02-23 CR CR20150092A patent/CR20150092A/es unknown
- 2015-07-02 HK HK15106284.5A patent/HK1206008A1/xx not_active IP Right Cessation
-
2016
- 2016-02-12 US US15/042,924 patent/US9650377B2/en active Active
-
2017
- 2017-04-28 US US15/581,642 patent/US20170305903A1/en not_active Abandoned
- 2017-06-28 JP JP2017125822A patent/JP2017226661A/ja not_active Withdrawn
-
2018
- 2018-05-29 HR HRP20180850TT patent/HRP20180850T1/hr unknown
- 2018-06-07 CY CY181100599T patent/CY1120728T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120031T1 (el) | Αποπτωτικοι υποκινητες ν-ακυλοσουλφοναμιδης | |
| CY1118340T1 (el) | Αναστολεις κινασης | |
| CY1119134T1 (el) | Υποδοχεις της νεπριλυσινης | |
| CY1121804T1 (el) | Καινοτομες ενωσεις πυριμιδινης και πυριδινης και η χρηση τους | |
| CY1120104T1 (el) | Αναστολεις της syk | |
| CY1124000T1 (el) | Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες σε κρυσταλλικη μορφη | |
| CY1121694T1 (el) | Ενωσεις δι-κυκλικου-συντηγμενου ετεροαρυλιου ή αρυλιου και η χρηση αυτων ως αναστολεις irak4 | |
| CY1121188T1 (el) | Αμιδο-υποκατεστημενες ετεροκυκλικες ενωσεις χρησιμες ως διαμορφωτες των αποκρισεων il-12, il-23 και/η ifn-αλφα | |
| CY1118973T1 (el) | Παραγωγα αμιδιου βενζοϊμιδαζολο-καρβοξυλικου οξεος για τη θεραπεια μεταβολικων ή καρδιαγγειακων νοσηματων | |
| CY1122730T1 (el) | 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων | |
| CY1117105T1 (el) | Ενωσεις πυριδαζινονης και χρηση τους ως αναστολεις του daao | |
| CY1118735T1 (el) | Παραγωγα βενζιμιδαζολο-προλινης | |
| CY1120318T1 (el) | Υποκατεστημενες βενζυλινδαζολες για χρηση ως αναστολεις κινασης bub1 στη θεραπευτικη αντιμετωπιση υπερπολλαπλασιαστικων ασθενειων | |
| CY1121549T1 (el) | Ενωσεις 1-αρυλκαρβονυλ-4-oξυ-πιπεριδινης χρησιμες για την αγωγη νευροεκφυλιστικων παθησεων | |
| CY1119056T1 (el) | Παραγωγα 2',4',-διφθορο-2'-μεθυλ υποκατεστημενου νουκλεοσιδιου ως αναστολεις αντιγραφης hcv rna | |
| CY1119620T1 (el) | Αναστολεις νεπριλυσινης | |
| CY1118129T1 (el) | 5-αλκυνυλ-πυριμιδινες | |
| CY1118379T1 (el) | Αναστολεις ιου ηπατιτιδας c | |
| CY1123627T1 (el) | Παραγωγα διυδροϊμιδαζοπυραζινονης χρησιμα στη θεραπευτικη αντιμετωπιση του καρκινου | |
| CY1118656T1 (el) | Παραγωγο πυριδονης | |
| CY1121631T1 (el) | Ενωση πυραζολης και φαρμακευτικη χρηση εξ αυτης | |
| CY1123811T1 (el) | Κρυσταλλικη μορφη αναστολεα pde4 | |
| CY1119953T1 (el) | Yποκατεστημενες πυριδοπυραζινες ως προτυποι syk ανοστολεις | |
| CY1120008T1 (el) | Βενζαμιδια | |
| CY1119619T1 (el) | Παραγωγα πυριδιν-4-υλιου |